Survey of treatment recommendations for anaplastic oligodendroglioma
Open Access
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 9 (3) , 314-318
- https://doi.org/10.1215/15228517-2007-002
Abstract
Anaplastic oligodendroglioma is a malignant brain tumor uniquely sensitive to treatment with both chemotherapy and radiotherapy. There are few prospeKeywords
This publication has 17 references indexed in Scilit:
- Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of ResponseJournal of Clinical Oncology, 2006
- Genetic analyses for predictors of radiation response in glioblastomaInternational Journal of Radiation Oncology*Biology*Physics, 2005
- The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsCancer, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971Journal of Clinical Oncology, 2003
- Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972Annals of Oncology, 2003
- Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro-OncologyJournal of Neuropathology and Experimental Neurology, 2003
- Histopathological-Molecular Genetic Correlations in Referral Pathologist-Diagnosed Low-Grade “Oligodendroglioma”Journal of Neuropathology and Experimental Neurology, 2002
- Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomasInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Successful chemotherapy for recurrent malignant oligodendrogliomaAnnals of Neurology, 1988